Surface display of p75, a Lactobacillus rhamnosus GG derived protein, on Bacillus subtilis spores and its antibacterial activity against Listeria monocytogenes

• Published in: AMB Express 2020-08, Vol.10 (1), p.139-139, Article 139
• Main Authors: Kang, Soo Ji, Jun, Ji Su, Moon, Jeong A, Hong, Kwang Won
• Format: Article
• Language: English
• Subjects: Anchoring; Antibacterial activity; Apoptosis; Bacillus subtilis; Biomedical and Life Sciences; Biotechnology; Cell walls; Coat protein; Epithelial cells; Genetic engineering; Hydrolase; Intestine; L. monocytogenes; Lactobacilli; Lactobacillus rhamnosus; Life Sciences; Listeria; Listeria monocytogenes; Microbial Genetics and Genomics; Microbiology; Ninhydrin; Original; Original Article; p75 Protein; Peptidoglycan hydrolase; Probiotics; Proteins; Scanning electron microscopy; Spore coats; Spore surface display; Spores
• ISSN: 2191-0855; 2191-0855
• DOI: 10.1186/s13568-020-01073-9

Lactobacillus rhamnosus p75 protein with peptidoglycan hydrolase (PGH) activity is one of the key molecules exhibiting anti-apoptotic and cell-protective activity for human intestinal epithelial cells. In this study, with the goal of developing new probiotics, the p75 protein was displayed on the surface of Bacillus subtilis spores using spore coat protein CotG as an anchoring motif. The PGH activity, stability, and the antibacterial activity of the spore-displayed p75 (CotG-p75) protein were also investigated. The PGH activity of the CotG-p75 against peptidoglycan extracted from B. subtilis was confirmed by the ninhydrin test. Under various harsh conditions, compared to the control groups, the PGH activities of CotG-p75 were very stable in the range of pH 3–7 and maintained at 70% at 50 °C. In addition, the antibacterial activity of CotG-p75 against Listeria monocytogenes was evaluated by a time-kill assay. After 6 h incubation in phosphate-buffered saline, CotG-p75 reduced the number of viable cells of L. monocytogenes by up to 2.0 log. Scanning electron microscopy analysis showed that the cell wall of L. monocytogenes was partially damaged by the treatment with CotG-p75. Our preliminary results show that CotG-p75 could be a good candidate for further research to develop new genetically engineered probiotics.